Overview The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers Status: Completed Trial end date: 2014-09-01 Target enrollment: Participant gender: Summary The purpose of this study in to evaluate safety, tolerability, pharmacokinetics of JPI-289 in healthy male subjects. Phase: Phase 1 Details Lead Sponsor: Jeil Pharmaceutical Co., Ltd.